Profilo
David L.
Guy has been Chief Commercial Officer of Favrille, Inc. since December 2005.
Previously, he served as Vice President of Global Strategic Marketing and Business Development and Oncology for Schering AG/Berlex from 2002 to 2005 and as Director of Oncology Marketing for Genentech from 2000 to 2001.
Mr. Guy was US Business Unit Head of Oncology for Sanofi-Aventis from 1994 to 2000.
He received a BS degree in Biology and Molecular Genetics from McMaster University in Hamilton, Ontario.
Precedenti posizioni note di David L. Guy
| Società | Posizione | Fine |
|---|---|---|
| Favrille, Inc. | Corporate Officer/Principal | 22/04/2009 |
| Bayer Schering Pharma AG | Corporate Officer/Principal | 01/01/2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Vendite & Marketing | 01/01/2001 |
| SANOFI | Corporate Officer/Principal | 01/01/2000 |
Formazione di David L. Guy
| McMaster University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SANOFI | Health Technology |
| Aziende private | 3 |
|---|---|
| Favrille, Inc. | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- David L. Guy
